XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2019
Stockholders' Equity Note [Abstract]  
Schedule of preferred stock dividend declaration and payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2019 through June 30, 2019:

Declaration Date
 
Record Date
 
Payment Date
 
Dividend Per Share
May 20, 2019
 
June 3, 2019
 
June 28, 2019
 
$
0.46875

February 15, 2019
 
March 3, 2019
 
March 29, 2019
 
0.46875
Schedule of cash dividends declared on common stock
The following table presents cash dividends declared by the Company on its common stock from January 1, 2019 through June 30, 2019:
 
Declaration Date (1)
 
Record Date
 
Payment Date
 
Dividend Per Share
 
June 12, 2019
 
July 1, 2019
 
July 31, 2019
 
$
0.20

(1)
March 6, 2019
 
March 29, 2019
 
April 30, 2019
 
0.20

 
 
(1)  At June 30, 2019, the Company had accrued dividends and dividend equivalents payable of $90.4 million related to the common stock dividend declared on June 12, 2019.
Schedule of sale of stock
The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the year ended December 31, 2018:

Share Issue Date
 
Shares Issued
 
Gross Proceeds Per Share
 
Gross Proceeds
(In Thousands, Except Per Share Amounts)
 
 
 
 
 
 
 
August 7, 2018
 
50,875

(1)
$7.78
 
$395,807
(1)

(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.4 million of underwriting discounts and related expenses in connection with this equity offering.
Schedule of changes in balances of each component of the entity's AOCI
The following table presents changes in the balances of each component of the Company’s AOCI for the three and six months ended June 30, 2019:
 
 
Three Months Ended
June 30, 2019
 
Six Months Ended
June 30, 2019
(In Thousands)
 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)/Gain
on Swaps
 
Total AOCI
 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
Gain/(Loss)
on Swaps
 
Total AOCI
Balance at beginning of period
 
$
422,261

 
$
(7,665
)
 
$
414,596

 
$
417,167

 
$
3,121

 
$
420,288

OCI before reclassifications
 
24,008

 
(19,706
)
 
4,302

 
44,307

 
(30,151
)
 
14,156

Amounts reclassified from AOCI (1)
 
(6,371
)
 
(743
)
 
(7,114
)
 
(21,576
)
 
(1,084
)
 
(22,660
)
Net OCI during the period (2)
 
17,637

 
(20,449
)
 
(2,812
)
 
22,731

 
(31,235
)
 
(8,504
)
Balance at end of period
 
$
439,898

 
$
(28,114
)
 
$
411,784

 
$
439,898

 
$
(28,114
)
 
$
411,784


(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
 

The following table presents changes in the balances of each component of the Company’s AOCI for the three and six months ended June 30, 2018:
 
 
Three Months Ended
June 30, 2018
 
Six Months Ended
June 30, 2018
(In Thousands)
 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
Gain
on Swaps
 
Total AOCI
 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)/Gain
on Swaps
 
Total AOCI
Balance at beginning of period
 
$
574,485

 
$
8,245

 
$
582,730

 
$
620,648

 
$
(11,424
)
 
$
609,224

OCI before reclassifications
 
(20,756
)
 
7,915

 
(12,841
)
 
(56,639
)
 
27,584

 
(29,055
)
Amounts reclassified from AOCI (1)
 
(5,178
)
 
—

 
(5,178
)
 
(15,458
)
 
—

 
(15,458
)
Net OCI during the period (2)
 
(25,934
)
 
7,915

 
(18,019
)
 
(72,097
)
 
27,584

 
(44,513
)
Balance at end of period
 
$
548,551

 
$
16,160

 
$
564,711

 
$
548,551

 
$
16,160

 
$
564,711


(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
Information about the significant amounts reclassified out of the entity's AOCI
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and six months ended June 30, 2019:
 
 
Three Months Ended
June 30, 2019
 
Six Months Ended
June 30, 2019
 
 
Details about AOCI Components
 
Amounts Reclassified from AOCI
 
Affected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
 
 
 
 
 
 
AFS Securities:
 
 
 
 
 
 
Realized gain on sale of securities
 
$
(6,371
)
 
$
(21,576
)
 
Net realized gain on sales of residential mortgage securities
Total AFS Securities
 
$
(6,371
)
 
$
(21,576
)
 
 
Swaps designated as cash flow hedges:
 
 
 
 
 
 
Amortization of de-designated hedging instruments
 
(743
)
 
(1,084
)
 
Other, net
Total Swaps designated as cash flow hedges
 
$
(743
)
 
$
(1,084
)
 
 
Total reclassifications for period
 
$
(7,114
)
 
$
(22,660
)
 
 
 
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and six months ended June 30, 2018:
 
 
Three Months Ended
June 30, 2018
 
Six Months Ended
June 30, 2018
 
 
Details about AOCI Components
 
Amounts Reclassified from AOCI
 
Affected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
 
 
 
 
 
 
AFS Securities:
 
 
 
 
 
 
Realized gain on sale of securities
 
$
(5,178
)
 
$
(15,458
)
 
Net realized gain on sales of residential mortgage securities
Total AFS Securities
 
$
(5,178
)
 
$
(15,458
)
 
 
Total reclassifications for period
 
$
(5,178
)
 
$
(15,458
)